Isolate #
|
AMP
|
GEN
|
ERY
|
TET
|
MXF
|
NIT
|
DAPa
|
LIZ
|
TEC
|
VAN
|
vanA
|
vanB
|
---|
EM0085
|
S
|
S
|
R
|
R
|
S
|
S
|
N
|
S
|
S
|
R
|
–
|
–
|
EM0176
|
S
|
S
|
R
|
S
|
S
|
I
|
N
|
S
|
S
|
R
|
+
|
–
|
EM3113
|
S
|
S
|
R
|
R
|
S
|
S
|
N
|
S
|
S
|
R
|
–
|
–
|
EM0476
|
S
|
S
|
S
|
S
|
I
|
S
|
N
|
S
|
R
|
R
|
+
|
–
|
EM2016
|
S
|
S
|
R
|
R
|
S
|
S
|
S
|
S
|
S
|
R
|
–
|
+
|
EM0040
|
S
|
S
|
S
|
S
|
R
|
S
|
N
|
S
|
S
|
R
|
–
|
–
|
EM0049
|
S
|
S
|
S
|
S
|
R
|
S
|
N
|
S
|
S
|
R
|
+
|
–
|
EM0149
|
S
|
S
|
S
|
S
|
I
|
S
|
S
|
S
|
S
|
R
|
–
|
–
|
EM0477
|
S
|
S
|
S
|
S
|
I
|
S
|
S
|
I
|
R
|
R
|
+
|
–
|
EM1161
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
R
|
–
|
+
|
EM0162
|
S
|
S
|
I
|
S
|
R
|
S
|
N
|
R
|
R
|
R
|
+
|
–
|
EM0074
|
S
|
S
|
S
|
S
|
I
|
S
|
S
|
S
|
S
|
R
|
–
|
–
|
EM0014
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
R
|
–
|
–
|
EM0116
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
R
|
–
|
+
|
EM0022
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
R
|
–
|
–
|
EM0056
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
R
|
–
|
–
|
EM0099
|
S
|
S
|
S
|
S
|
S
|
S
|
N
|
S
|
S
|
R
|
–
|
–
|
EM0010
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
R
|
+
|
–
|
EM0018
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
R
|
–
|
–
|
EM1009
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
R
|
–
|
–
|
Total R/+ (%)
|
0
|
0
|
04 (20)
|
03 (15)
|
03 (15)
|
0
|
0
|
01 (5)
|
03 (15)
|
20 (100)
|
06 (30)
|
03 (15)
|
- E. casseliflavus & Enterococcus gallinarum are intrinsically resistant to vancomycin
- AMP ampicillin, VAN vancomycin; aGEN high level gentamicin, ERY erythromycin, TET tetracyclin, MXF moxifloxacin, NIT nitrofurantoin, DAP daptomycin, TEC teicoplanin, LIZ linezolid, S Susceptible, I Intermediate, R Resistant, N non-susceptible; −, Negative; +, Positive